DK677688D0 - Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne - Google Patents

Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne

Info

Publication number
DK677688D0
DK677688D0 DK677688A DK677688A DK677688D0 DK 677688 D0 DK677688 D0 DK 677688D0 DK 677688 A DK677688 A DK 677688A DK 677688 A DK677688 A DK 677688A DK 677688 D0 DK677688 D0 DK 677688D0
Authority
DK
Denmark
Prior art keywords
human
somatometricated
procedures
manufacturing
protein substances
Prior art date
Application number
DK677688A
Other languages
Danish (da)
English (en)
Other versions
DK677688A (da
Inventor
Emerald Martin Spencer
Original Assignee
Biogrowth Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogrowth Inc filed Critical Biogrowth Inc
Publication of DK677688A publication Critical patent/DK677688A/da
Publication of DK677688D0 publication Critical patent/DK677688D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK677688A 1987-04-06 1988-12-05 Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne DK677688D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3488587A 1987-04-06 1987-04-06
PCT/US1988/001042 WO1988007863A1 (fr) 1987-04-06 1988-03-31 Sous-unites de proteines porteuses de somatomedine humaine et leur procede de fabrication

Publications (2)

Publication Number Publication Date
DK677688A DK677688A (da) 1988-12-05
DK677688D0 true DK677688D0 (da) 1988-12-05

Family

ID=21879212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK677688A DK677688D0 (da) 1987-04-06 1988-12-05 Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne

Country Status (11)

Country Link
EP (2) EP0308500B1 (fr)
JP (1) JP2648951B2 (fr)
AT (1) ATE90690T1 (fr)
AU (1) AU627423B2 (fr)
CA (1) CA1340295C (fr)
DE (1) DE3881801T2 (fr)
DK (1) DK677688D0 (fr)
ES (1) ES2058341T3 (fr)
IL (1) IL85983A (fr)
WO (1) WO1988007863A1 (fr)
ZA (1) ZA882407B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973115A (en) * 1987-05-15 1999-10-26 Amgen Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
AU1955388A (en) * 1988-04-12 1989-11-03 Synergen, Inc. Method for potentiating and inhibiting insulin-like growth factor activity
EP0424416B1 (fr) * 1988-07-15 1995-07-19 Central Sydney Area Health Service Sous-unite labile aux acides d'un complexe proteique de liaison du facteur de croissance analogue a l'insuline
US6465423B1 (en) 1988-07-15 2002-10-15 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
EP0800530A4 (fr) * 1994-07-20 1998-12-02 Celtrix Pharma Complexe igf/igfbp destines a favoriser la formation osseuse et a reguler le remodelage osseux
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
PT1141014E (pt) 1999-01-06 2005-04-29 Genentech Inc Variante mutante do factor de crescimento semelhante a insulina (igf-i)
JP2002535967A (ja) 1999-01-06 2002-10-29 ジェネンテック・インコーポレーテッド インシュリン様成長因子（ｉｇｆ）ｉ変異体
EP1282437B1 (fr) 2000-05-16 2008-03-19 Genentech, Inc. Traitement des lesions du cartilage
EP1401476A4 (fr) 2001-03-14 2006-03-08 Genentech Inc Peptides antagonistes d'igf
EP1622942B1 (fr) 2003-05-01 2014-11-19 ImClone LLC Anticorps entierement humains diriges contre le recepteur du facteur de croissance 1 de type insuline
DK2274978T3 (en) 2003-09-12 2015-06-15 Ipsen Biopharmaceuticals Inc Methods of treating an insulin-like growth factor-I (IGF-I) deficiency
JP2007537711A (ja) 2003-10-03 2007-12-27 ジェネンテック・インコーポレーテッド Ｉｇｆ結合タンパク質
US8128929B2 (en) 2005-06-17 2012-03-06 Imclone Llc Antibodies against PDGFRa
AP2008004569A0 (en) 2006-02-03 2008-08-31 Imclone Systems Inc IGR-IR antagonists as adjuvants for treatment of prostrate cancer
EA202090705A1 (ru) 2017-09-11 2020-06-11 Шайр Хьюман Дженетик Терапиз, Инк. Способы и композиции, предназначенные для лечения хронических заболеваний легких
CA3194764A1 (fr) 2020-10-19 2022-04-28 Oak Hill Bio Limited Compositions appropriees pour une utilisation chez des nouveau-nes
WO2023139115A1 (fr) 2022-01-19 2023-07-27 Oak Hill Bio Limited Compositions et procédés pour réduire l'oxydation d'igf‐1/igfbp
WO2023242439A1 (fr) 2022-06-17 2023-12-21 Oak Hill Bio Limited Stabilisation vasculaire (nourrissons prématurés)
WO2023242442A1 (fr) 2022-06-17 2023-12-21 Oak Hill Bio Limited Procédé de maturation/différenciation de neurones et/ou de modulation du nerf vague
WO2023242440A1 (fr) 2022-06-17 2023-12-21 Oak Hill Bio Limited Traitement des poumons chez les nourrissons

Also Published As

Publication number Publication date
IL85983A (en) 1994-10-07
ES2058341T3 (es) 1994-11-01
WO1988007863A1 (fr) 1988-10-20
AU1702088A (en) 1988-11-04
DE3881801D1 (de) 1993-07-22
JPH01502986A (ja) 1989-10-12
EP0308500B1 (fr) 1993-06-16
DE3881801T2 (de) 1993-12-23
DK677688A (da) 1988-12-05
EP0294021A1 (fr) 1988-12-07
AU627423B2 (en) 1992-08-27
JP2648951B2 (ja) 1997-09-03
IL85983A0 (en) 1988-09-30
CA1340295C (fr) 1998-12-29
ZA882407B (en) 1988-09-28
EP0308500A1 (fr) 1989-03-29
ATE90690T1 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
DK677688A (da) Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne
DK95291A (da) Rekombinante dna-molekyler
DK564989A (da) Bindingsproteiner
US5043429B1 (en) Protein fragments containing factor VIII binding domain of von willebrand factor
WO1994004691A3 (fr) Formes dimeres et multimeres de polypeptides monocatenaires
NZ224057A (en) A polypeptide of a vascular anticoagulant protein and method of preparation
DE69000338D1 (de) Expressionssystem zur herstellung von chimaeren monoklonalen antikoerpern.
FI97299C (fi) Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi
FI953525A (fi) Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
HUT55800A (en) Process for producing anticoagulant peptides
AU576508B2 (en) Sythetic peptides antigenically corresponding to brain specific proteinoids
DE3881101D1 (de) Monoklonal-antikoerper und methode fuer die bereitung von hybridoma, produzierend diese antikoerper.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment